Dr Wild & Co. Ltd was founded in 1932 by Dr Samuel Wild and Werner Wild as an independent and self-supporting company, which it still is. At the time, it was a great challenge to take up the development, manufacture and quality control of medicines. Until the end of the second World War, the main market was Switzerland.
In the 1940ies a whole range of dental care products was developed and manufactured thanks to a close and fruitful collaboration with dental universities and physicians. During this pioneering work, Dr Wild succeeded in adding therapeutically active ingredients to toothpastes, mouthwashes, gingival pastes and gels.
The first products to appear on the market were the EMOFORM medicated toothpastes, which are famous today in more than 50 countries worldwide. In the course of time, new products were developed like EMOFRESH, GINVAPAST and DEPURDENT. Dr Wild also took over from Roche Consumer Health the worldwide distribution of DEAFTOL mouthspray and tablets for the treatment of aphthae, inflammation of the oral mucosa and denture pressure spots.
| Contact Details: |
| Lange Gasse 4P.O. Box 4644 |
| BASEL |
| |
| 4002 |
| Switzerland |
| Tel: | 41 61 279 90 00 |
| Fax: | 41 61 279 90 09 |
| Email: | info@wild-pharma.com |
| WWW: | www.wild-pharma.com/
|
| |
Recent Publications by Dr. Wild & Co. Ltd.: |  |
The aldo-keto reductase Akr1b7 gene is a common transcriptional target of xenobiotic receptors PXR and CAR.
AKR1B7 (aldo-keto reductase family 1, member 7), a member of the AKR... | 23rd June, 2009
| University of Pittsburgh.
| Mol Pharmacol. 2009 Jun 19.
DOI Direct Link |
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLC.
Dr. Camidge: To summarize, this patient is a relatively young, otherwise... | 30th May, 2009
| Thoracic Oncology Program, University of Colorado Comprehensive Cancer
| Oncology (Williston Park). 2009 Apr 30;23(5):424-9.
|
Lack of Adaptation of Chimeric GBV-B/Hepatitis C Virus in the Marmoset Model: Possible Effects of Bottleneck.
Approximately 3% of the world population is chronically infected with... | 29th May, 2009
| Department of Virology and Immunology, Southwest Foundation for Biomedical
| J Virol. 2009 May 27.
DOI Direct Link |
High-frequency ultrasound to grade disease progression in murine models of Duchenne muscular dystrophy.
OBJECTIVE: This study used high-frequency ultrasound (HFU) imaging to... | 28th May, 2009
| Imaging Research Laboratories, Robarts Research Institute, 100 Perth Dr,
| J Ultrasound Med. 2009 Jun;28(6):707-16.
|
Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.
PURPOSE: Alzheimer s disease is characterized by a dysfunction of central... | 28th May, 2009
| Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech
| J Pharm Pharm Sci. 2009;12(1):79-85.
|
→View more Dr. Wild & Co. Ltd. research publications. |
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 2057 individuals from Dr. Wild & Co. Ltd. using this service.
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 756 times since April 2007, the link to the organisation's website has been followed 151 times
Recent Search Terms used to find this page: Wild pharma | Dr Wild | ultrastructural study of the life cycle of r slovaca | dr.wild.ch | dr wild | Wild co | Dr. Wild Co | t | Dr. Wild Co. | Dr. Wild co.ltd | .
Search for more companies in BASEL
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Dr. Wild & Co. Ltd.
